Literature DB >> 6362559

Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections.

F D Pien.   

Abstract

A total of 88 patients were enrolled in a double-blind comparison of cefaclor and amoxicillin-clavulanic acid for the outpatient treatment of soft tissue infections (abscesses, cellulitis, and impetigo). In 84 clinically evaluable patients, high cure rates were obtained for all treatment groups (64 to 85%). Patients who received amoxicillin-clavulanic acid had a much higher incidence of gastrointestinal side effects than did patients who received cefaclor (34 versus 3%, P less than 0.005). However, only five patients with gastrointestinal reactions to amoxicillin-clavulanic acid had symptoms severe enough to warrant halting the completion of antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6362559      PMCID: PMC185396          DOI: 10.1128/AAC.24.6.856

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Cefaclor in management of streptococcal pharyngitis, otitis media, and skin infections.

Authors:  R B Kammer
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1981 May-Jun

2.  In vitro activity of augmentin against pathogenic bacteria and its comparison with other antibiotics.

Authors:  F Perryman; S Johnson; S M Qadri
Journal:  Chemotherapy       Date:  1983       Impact factor: 2.544

3.  Effect of food on the bioavailability and tolerance of clavulanic acid/amoxycillin combination.

Authors:  D H Staniforth; R J Lillystone; D Jackson
Journal:  J Antimicrob Chemother       Date:  1982-08       Impact factor: 5.790

4.  Clinical efficacy and tolerance of Augmentin in soft tissue infection.

Authors:  A P Ball; S Mehtar; A Watson
Journal:  J Antimicrob Chemother       Date:  1982-07       Impact factor: 5.790

5.  A double-blind study comparing cefaclor and amoxycillin in the treatment of respiratory tract infections in general practice.

Authors:  N H Brodie; R L McGhie; H O'Hara; J O'Hara; M K Rahman; J C Vallé-Jones
Journal:  Pharmatherapeutica       Date:  1980

6.  Comparative activity of BRL 25.000 with amoxycillin against resistant clinical isolates.

Authors:  H W Van Landuyt; M Pyckavet; A M Lambert
Journal:  J Antimicrob Chemother       Date:  1981-01       Impact factor: 5.790

7.  An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogens.

Authors:  A L Barry; F Garcia; L D Thrupp
Journal:  Am J Clin Pathol       Date:  1970-02       Impact factor: 2.493

8.  Diagnosis and treatment: drugs five years later. Amoxicillin.

Authors:  H C Neu
Journal:  Ann Intern Med       Date:  1979-03       Impact factor: 25.391

9.  Cefaclor and amoxycillin in the treatment of infective exacerbations of chronic bronchitis.

Authors:  M R Law; H A Holt; D S Reeves; M E Hodson
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

Review 10.  Evaluation of cefaclor.

Authors:  J E Derry
Journal:  Am J Hosp Pharm       Date:  1981-01
View more
  5 in total

Review 1.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

Review 2.  Interventions for impetigo.

Authors:  Sander Koning; Renske van der Sande; Arianne P Verhagen; Lisette W A van Suijlekom-Smit; Andrew D Morris; Christopher C Butler; Marjolein Berger; Johannes C van der Wouden
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

3.  Randomized controlled trial of prophylactic antibiotics for dog bites with refined cost model.

Authors:  James V Quinn; Daniel McDermott; Jennifer Rossi; John Stein; Nathan Kramer
Journal:  West J Emerg Med       Date:  2010-12

4.  Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections.

Authors:  T M File; J S Tan; S J Salstrom; L A Johnson; G F Douglas
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

Review 5.  Interventions for cellulitis and erysipelas.

Authors:  Sally A Kilburn; Peter Featherstone; Bernie Higgins; Richard Brindle
Journal:  Cochrane Database Syst Rev       Date:  2010-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.